Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Trevanne Matthews Hew"'
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 7 (2019)
Triple-negative breast cancer (TNBC) accounts for 20% of breast cancers diagnosed worldwide. This subtype of breast cancer tends to behave more aggressively, and unlike other breast cancer subtypes, there are no standard targeted treatments for most
Externí odkaz:
https://doaj.org/article/e8f4856ca7d74082a12e250def47e2a9
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 6 (2018)
We report the case of a patient with B-cell prolymphocytic leukemia who was successfully treated with the novel humanized monoclonal antibody obinutuzumab. This patient was previously treated with the combination of rituximab and bendamustine and had
Externí odkaz:
https://doaj.org/article/3b9ed46976574f3f92111bfe59faaec4
Autor:
Bharatsinh Gharia MD, Karan Seegobin MD, Hetavi Mahida MD, Marwan Shaikh MD, Trevanne Matthews Hew MD, Dat Pham MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 6 (2018)
Type B lactic acidosis associated with malignancy is a life-threatening complication and mostly seen in hematological malignancies but can also be seen in solid tumors. We report a rare case of a 64-year-old female diagnosed with metastatic adenocarc
Externí odkaz:
https://doaj.org/article/a0bd3b01bc0b406faaaaf8b08df9fe98
Publikováno v:
Journal of Hematology. 12:100-104
Publikováno v:
Cureus
Lung cancer is a worldwide concern and is the leading cause of cancer-related death in the United States. Adenocarcinoma is the most common type of non-small cell lung cancer; however, unlike other types of lung cancer this disease is often seen in l
Autor:
Dat C. Pham, Trevanne Matthews Hew, Ian Tfirn, Jason Hew, Hardik Satish Chhatrala, Shiva Gautam, Meet Kadakia
Publikováno v:
Journal of Clinical Oncology. 38:233-233
233 Background: While prostate cancer mortality has declined in the in the general population, it remains high in African Americans. The aim of our study is to determine whether race and insurance type affect treatment outcomes in prostate cancer pat
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports
Journal of Investigative Medicine High Impact Case Reports, Vol 6 (2018)
Journal of Investigative Medicine High Impact Case Reports, Vol 6 (2018)
We report the case of a patient with B-cell prolymphocytic leukemia who was successfully treated with the novel humanized monoclonal antibody obinutuzumab. This patient was previously treated with the combination of rituximab and bendamustine and had
Autor:
Lara Zuberi, Trevanne Matthews Hew
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 7 (2019)
Journal of Investigative Medicine High Impact Case Reports
Journal of Investigative Medicine High Impact Case Reports
Triple-negative breast cancer (TNBC) accounts for 20% of breast cancers diagnosed worldwide. This subtype of breast cancer tends to behave more aggressively, and unlike other breast cancer subtypes, there are no standard targeted treatments for most
Autor:
Marwan Shaikh, Trevanne Matthews Hew, Dat C. Pham, Karan Seegobin, Hetavi Mahida, Bharatsinh Gharia
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 6 (2018)
Journal of Investigative Medicine High Impact Case Reports
Journal of Investigative Medicine High Impact Case Reports
Type B lactic acidosis associated with malignancy is a life-threatening complication and mostly seen in hematological malignancies but can also be seen in solid tumors. We report a rare case of a 64-year-old female diagnosed with metastatic adenocarc